Keyphrases
Congestive Heart Failure
100%
Vasopressin V2 Receptor Antagonist
100%
Tolvaptan
100%
Phase II Trial
50%
Volume Homeostasis
50%
Pharmacology
25%
Cirrhosis
25%
Kidney
25%
Health Care Costs
25%
Pharmacokinetics
25%
Hospital Admission
25%
Arginine Vasopressin
25%
Vasopressin V2 Receptor
25%
Highly Selective
25%
Hemodynamic Profile
25%
Collecting Tubules
25%
Renal Insufficiency
25%
Neurohormone
25%
Electrolyte Abnormalities
25%
Volume Status
25%
Osmotic Balance
25%
Neurohormonal Activation
25%
Abnormal Volume
25%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor Antagonist
100%
Congestive Heart Failure
100%
Tolvaptan
100%
Vasopressin
100%
Disease
25%
Receptor
25%
Liver Cirrhosis
25%
Argipressin
25%
Phase II Trials
25%
Kidney Failure
25%
Neurohormone
25%
Pharmacokinetics
25%